Xbrane Biopharma AB (publ) (STO:XBRANE)

Sweden · Delayed Price · Currency is SEK

13.00

-1.15 (-8.13%)

Nov 2, 2026, 5:29 PM CET

Xbrane Biopharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	268	210	246	297	2,258	2,624
Market Cap Growth	23.46%	-14.54%	-17.28%	-86.83%	-13.94%	58.03%
Enterprise Value	294	117	386	371	2,133	2,285
Last Close Price	14.15	10.20	20.10	1250.00	10262.50	13100.00

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	1.65	-	-	-	-
Forward PE	-	2.45	18.40	27.74	13.18	20.01
PS Ratio	2.28	1.38	1.66	1.25	39.19	245.04
PB Ratio	0.55	0.38	1.18	1.74	5.32	6.08
P/TBV Ratio	1.46	0.38	1.18	1.74	5.32	6.08

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.49	0.77	2.60	1.56	37.03	213.37

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.12	0.10	0.92	1.35	0.09	0.10
Debt / FCF Ratio	0.95	-	-	-	-	-
Net Debt / Equity Ratio	0.05	-0.05	0.32	0.97	-0.37	-0.58
Net Debt / EBITDA Ratio	-0.55	1.44	-0.92	-0.58	1.07	1.46
Net Debt / FCF Ratio	0.39	0.11	-0.50	-0.40	0.76	1.01
Asset Turnover	0.19	0.20	0.20	0.36	0.08	0.02
Inventory Turnover	0.62	0.28	0.10	2.59	-	-
Quick Ratio	0.66	2.43	0.40	0.42	1.02	1.84
Current Ratio	3.21	7.12	1.13	1.41	2.17	2.55
Return on Equity (ROE)	-11.10%	-12.00%	-74.40%	-108.02%	-39.34%	-53.15%
Return on Assets (ROA)	-4.28%	-1.65%	-6.88%	-27.60%	-13.84%	-19.14%
Return on Capital Employed (ROCE)	-8.50%	-3.20%	-27.00%	-90.80%	-33.60%	-37.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-23.40%	60.54%	-108.25%	-130.56%	-7.64%	-7.18%
FCF Yield	23.15%	-119.28%	-54.58%	-139.07%	-9.10%	-9.42%
Buyback Yield / Dilution	98.94%	-67.03%	-4184.59%	-12.26%	-8.38%	-30.25%